Literature DB >> 3002650

Japanese encephalitis: current worldwide status.

T Umenai, R Krzysko, T A Bektimirov, F A Assaad.   

Abstract

The changing epidemiological and distribution patterns of Japanese encephalitis in various southern and east Asian countries are described. Immunization is considered to be the only practical way to control the infection. Several vaccines have been developed and two types of inactivated vaccine are now available for use in man.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3002650      PMCID: PMC2536386     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  52 in total

1.  Japanese encephalitis.

Authors:  T Solomon; N M Dung; R Kneen; M Gainsborough; D W Vaughn; V T Khanh
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-04       Impact factor: 10.154

2.  Comparison of the genome sequences and the phylogenetic analyses of the GP78 and the Vellore P20778 isolates of Japanese encephalitis virus from India.

Authors:  S Vrati
Journal:  J Biosci       Date:  2000-09       Impact factor: 1.826

3.  Effect of enforced expression of human bcl-2 on Japanese encephalitis virus-induced apoptosis in cultured cells.

Authors:  C L Liao; Y L Lin; J J Wang; Y L Huang; C T Yeh; S H Ma; L K Chen
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

4.  Investigation of the genotype III to genotype I shift in Japanese encephalitis virus and the impact on human cases.

Authors:  Na Han; James Adams; Wei Fang; Si-Qing Liu; Simon Rayner
Journal:  Virol Sin       Date:  2015-08-18       Impact factor: 4.327

5.  Studies in the development of Japanese encephalitis vaccine: expression of virus envelope glycoprotein V3 (E) gene in yeast.

Authors:  H Fujita; H Sumiyoshi; C Mori; S Manabe; M Takagi; I Yoshida; K Morita; I Fuke; K Fukai; A Igarashi
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

6.  Japanese encephalitis virus latency in peripheral blood lymphocytes and recurrence of infection in children.

Authors:  S Sharma; A Mathur; V Prakash; R Kulshreshtha; R Kumar; U C Chaturvedi
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

7.  Japanese encephalitis vaccine in travellers. Is wider use prudent?

Authors:  T Jelinek; H D Nothdurft
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

8.  Japanese encephalitis: containing the growing threat.

Authors:  L Kant; D Mukherji
Journal:  Indian J Pediatr       Date:  1986 Sep-Oct       Impact factor: 1.967

Review 9.  Incubation periods of mosquito-borne viral infections: a systematic review.

Authors:  Kara E Rudolph; Justin Lessler; Rachael M Moloney; Brittany Kmush; Derek A T Cummings
Journal:  Am J Trop Med Hyg       Date:  2014-03-17       Impact factor: 2.345

10.  Japanese encephalitis virus infection of mouse cell lines: ability to prime mice for generation of virus specific cytotoxic T lymphocytes and differences in CTL recognisable viral determinants.

Authors:  K Murali-Krishna; V Ravi; R Manjunath
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.